Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cocoa May Help Suppress Colon Cancer

By LabMedica International staff writers
Posted on 14 Feb 2012
A new study on living lab rats has shown for the first time that eating cocoa can help prevent intestinal disorders associated with oxidative stress, including colon carcinogenesis onset caused by chemical compounds.

The growing interest among the scientists to identify those foods capable of preventing diseases has now branded cocoa as a “superfood.” It has been recognized as an excellent source of phytochemical compounds, which offer potential health benefits.

Led by scientists from the Institute of Food Science and Technology and Nutrition (ICTAN; Madrid, Spain) and published in the December 2011 issue of the Molecular Nutrition & Food Research journal, the new study supports this hypothesis and maintains the claim that cacao consumption helps to prevent intestinal problems associated oxidative stress, such as the onset of chemically induced colon carcinogenesis.

“Being exposed to different poisons in the diet like toxins, mutagens, and procarcinogens, the intestinal mucus is very susceptible to pathologies,” explained Dr. More...
María Ángeles Martín Arribas, lead author of the study and researcher at ICTAN. She added that, “foods like cocoa, which is rich in polyphenols, seems to play an important role in protecting against disease.”

The study on live rats has validated, for the first time, the potential protection effect that flavonoids in cocoa have against colon cancer onset. For eight weeks, the scientists of the study fed the rats with a cocoa-rich (12%) diet and carcinogenesis was induced.

Dr. Martín Arribas reported that, “four weeks after being administered with the chemical compound azoxymethane [AOM], intestinal mucus from premalignant neoplastic lesions appeared. These lesions are called ‘aberrant crypt foci’ and are considered to be good markers of colon cancer pathogenesis.”

The study’s findings revealed that the rats fed a cocoa-rich diet had a considerably reduced number of aberrant crypt foci in the colon induced by the carcinogen. Similarly, this sample saw an improvement in their endogenous antioxidant defenses and a decrease in the markers of oxidative damage induced by the toxic compound in this cell.

The researchers concluded that the protection effect of cocoa can block cell-signaling pathways involved in cell proliferation, and therefore, subsequent neoplasty and tumor formation. Lastly, the animals fed with the cocoa-rich diet showed an increase in apoptosis as a chemoprevention process against the development of the carcinogenesis.

Although more research is required to determine what bioactive compounds in cocoa are responsible for such effects, the authors concluded that a cocoa-rich diet seems capable of reducing induced oxidative stress. It could also have protection properties in the initial stages of colon cancer as it reduces premalignant neoplastic lesion formation.

Cocoa is one of the chief ingredients in chocolate. It is one of the richest foods in phenolic compounds, mainly in flavonoids such as procyanidins, catechins, and epicatechins, which have numerous beneficial biologic activities in the prevention of cardiovascular diseases and cancer (mainly colorectal cancer).

In fact, compared to other foods with high flavonoid content, cocoa has a high level of procyanidins with limited bioavailability. These flavonoids are therefore found in their highest concentrations in the intestine where they neutralize many oxidants.



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.